The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis

被引:0
|
作者
Yara Dadalti Fragoso
Patrick N. Stoney
Peter J. McCaffery
机构
[1] Universidade Metropolitana de Santos,Department of Neurology, MS Reference Center, Medical School
[2] University of Aberdeen,Institute of Medical Sciences
来源
CNS Drugs | 2014年 / 28卷
关键词
Multiple Sclerosis; Retinoic Acid; Retinol; Retinoic Acid Receptor; Retinoic Acid Signalling;
D O I
暂无
中图分类号
学科分类号
摘要
Vitamin A is an essential nutrient with important roles in immunological responses and in brain development. Its main metabolite is retinoic acid (RA), which is responsible for the neuroimmunological functions related to vitamin A. In the brain, RA is known to have interactions with other nuclear receptor-mediated signalling pathways. RA is involved in plasticity, regeneration, cognition and behaviour. In the peripheral blood, RA plays a major role both in increasing tolerance and in decreasing inflammation, through balancing T-lymphocyte populations. It is likely that RA synthesis may be manipulated by complex cross-talk among cells during infection and inflammation. The role of vitamin A in multiple sclerosis (MS) could be dual: at the same time as it decreases inflammation and increases tolerance of autoimmunity, it may also help in brain protection. The present review discusses the beneficial effects that vitamin A might have for controlling MS, although it must be clearly stated that, at the present time, there is no clear indication for using vitamin A as a treatment for MS. However, the results from the present review should encourage clinical trials with vitamin supplementation as a potential treatment or as an add-on option. Vitamin A acts in synergy with vitamin D, and the immunological homeostasis ensured by these vitamins should not be unbalanced in favour of only one of them.
引用
收藏
页码:291 / 299
页数:8
相关论文
共 50 条
  • [41] Multiple Sclerosis and Vitamin D
    Cantor, Fredric K.
    Richert, Nancy
    Cortese, Irene
    Ohayon, Joan
    Kaylan, Fenton
    McFarland, Henry
    NEUROLOGY, 2010, 74 (09) : A52 - A52
  • [42] Vitamin D and multiple sclerosis
    Hayes, CE
    Cantorna, MT
    Deluca, HF
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 216 (01): : 21 - 27
  • [43] Vitamin D and multiple sclerosis. The role for risk of disease and treatment
    Doering, A.
    Paul, F.
    Doerr, J.
    NERVENARZT, 2013, 84 (02): : 173 - 189
  • [44] Vitamin D and Multiple Sclerosis
    Weinstock-Guttman, Bianca
    Mehta, Bijal K.
    Ramanathan, Murali
    Karmon, Yuval
    Henson, Lily Jung
    Halper, June
    Riskind, Peter
    NEUROLOGIST, 2012, 18 (04) : 179 - 183
  • [45] Vitamin D and multiple sclerosis
    Pozuelo-Moyano, Beatriz
    Benito-Leon, Julian
    REVISTA DE NEUROLOGIA, 2013, 56 (04) : 243 - 251
  • [46] Vitamin D and multiple sclerosis
    Raghuwanshi, Anita
    Joshi, Sneha S.
    Christakes, Sylvia
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (02) : 338 - 343
  • [47] Vitamin D and multiple sclerosis
    Harandi, Asghar Amini
    Harandi, Ali Amini
    Pakdaman, Hossein
    Sahraian, Mohammad Ali
    IRANIAN JOURNAL OF NEUROLOGY, 2014, 13 (01) : 1 - 6
  • [48] Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: A potential therapeutic role
    Martin, Ruben
    Carvalho-Tavares, Juliana
    Hernandez, Marita
    Arnes, Mercedes
    Ruiz-Gutierrez, Valentina
    Luisa Nieto, Maria
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (02) : 198 - 208
  • [49] Interferon treatment is beneficial in early multiple sclerosis
    Charatan, F
    BRITISH MEDICAL JOURNAL, 2000, 321 (7265): : 851 - 851
  • [50] Vitamin D-binding protein and multiple sclerosis: Evidence, controversies, and needs
    Gauzzi, Maria Cristina
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1526 - 1535